Results 151 to 160 of about 183,390 (190)
Some of the next articles are maybe not open access.
Heterocyclic HIV-1 Protease Inhibitors
Organic Letters, 1999[formula: see text] A series of simple heterocyclic HIV-1 protease inhibitors were developed on the basis of size, shape, and electronic complementarity to the active site of the enzyme. The C2-symmetric heterocycles do not contain a transition-state isostere nor are they active site directed irreversible inhibitors; thus, they represent the success of
openaire +2 more sources
Perspectives in HIV Protease Inhibitors
1996The therapy of HIV-1, the causative agent of AIDS, is limited today to a small number of different drugs, all of which are nucleoside analogues. Nucleoside analogues active against HIV are all inhibitors of reverse transcriptase (RT) and target primarily early events in the replication cycle of HIV.
openaire +2 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Prevention, treatment and cure of HIV infection
Nature Reviews Microbiology, 2023Raphael J Landovitz +2 more
exaly
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Nature Reviews Microbiology, 2017Mahdad Noursadeghi
exaly